VirTech Bio
PrivateLast Round
VC Round
Dec 1, 2022
Total Funding Raised
$18.41M
Momentum Score
50 /100
Company Overview
VirTech Bio is a biotechnology company that develops a proprietary hemoglobin-based oxygen carrier (HBOC) solution for applications such as severe blood loss and organ preservation for transplants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Defense Tech
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VirTech Bio Comps
Public and private peers based on sector, stage, and business model.
VirTech Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2022 | ||||
| Seed | Nov 1, 2022 | ||||
| Grant | Aug 1, 2021 |
VirTech Bio Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 114% MoM.
- May 1, 2025
Monthly visitors increased 120% MoM, reaching 1.3K.
VirTech Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VirTech Bio's valuation, stock price, and market status.
